These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22715810)

  • 1. Chromophobe renal cell carcinoma: a review of an uncommon entity.
    Vera-Badillo FE; Conde E; Duran I
    Int J Urol; 2012 Oct; 19(10):894-900. PubMed ID: 22715810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
    Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
    Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral peripheral small papillary tufts: a diagnostic clue of renal tumors associated with Birt-Hogg-Dubé syndrome.
    Kuroda N; Furuya M; Nagashima Y; Gotohda H; Moritani S; Kawakami F; Imamura Y; Bando Y; Takahashi M; Kanayama HO; Ota S; Michal M; Hes O; Nakatani Y
    Ann Diagn Pathol; 2014 Jun; 18(3):171-6. PubMed ID: 24767893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology, therapy and prognosis of papillary renal carcinoma.
    Fernandes DS; Lopes JM
    Future Oncol; 2015; 11(1):121-32. PubMed ID: 25572787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation.
    Prasad SR; Humphrey PA; Catena JR; Narra VR; Srigley JR; Cortez AD; Dalrymple NC; Chintapalli KN
    Radiographics; 2006; 26(6):1795-806; discussion 1806-10. PubMed ID: 17102051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Uniparental Disomy and Copy Number Variations in Renal Cell Carcinomas Associated with Birt-Hogg-Dubé Syndrome.
    Iribe Y; Yao M; Tanaka R; Kuroda N; Nagashima Y; Nakatani Y; Furuya M
    Am J Pathol; 2016 Feb; 186(2):337-46. PubMed ID: 26776076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chromophobe renal cell carcinoma - case report].
    Krawiec K; Marks P; Różański W; Lipiński M
    Pol Merkur Lekarski; 2015 Feb; 38(224):100-3. PubMed ID: 25771519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Analysis of Smoking as a Risk Factor among Renal Cell Carcinoma Histological Subtypes.
    Patel NH; Attwood KM; Hanzly M; Creighton TT; Mehedint DC; Schwaab T; Kauffman EC
    J Urol; 2015 Sep; 194(3):640-6. PubMed ID: 25896558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
    Vermassen T; De Meulenaere A; Van de Walle M; Rottey S
    Acta Clin Belg; 2017 Feb; 72(1):12-18. PubMed ID: 27356035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leiomyomatous renal cell carcinoma - case report].
    Ulamec M; Tomasković I; Murgić J; Kruslin B
    Lijec Vjesn; 2011; 133(5-6):190-3. PubMed ID: 21888085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hybrid tumour 'oncocytoma-chromophobe renal cell carcinoma' of the kidney: a report of seven sporadic cases.
    Delongchamps NB; Galmiche L; Eiss D; Rouach Y; Vogt B; Timsit MO; Vieillefond A; Méjean A
    BJU Int; 2009 May; 103(10):1381-4. PubMed ID: 19154497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromophobe renal cell carcinoma in a child: case report and review of the literature.
    Katzman PJ; Schwartz JI
    Pediatr Dev Pathol; 2007; 10(2):125-8. PubMed ID: 17378685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tumors with clear cells. A review.
    López JI
    Pathol Res Pract; 2013 Mar; 209(3):137-46. PubMed ID: 23433880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
    Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association.
    Kanayama HO; Fukumori T; Fujimoto H; Nakanishi H; Ohyama C; Suzuki K; Nishiyama H; Eto M; Miki T; Kamoi K; Kubota Y; Takahashi S; Homma Y; Naito S
    Int J Urol; 2015 Sep; 22(9):S1-7. PubMed ID: 26332059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive review of chromophobe renal cell carcinoma.
    Garje R; Elhag D; Yasin HA; Acharya L; Vaena D; Dahmoush L
    Crit Rev Oncol Hematol; 2021 Apr; 160():103287. PubMed ID: 33753250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic options for variant renal cancer: a true orphan disease.
    Stadler WM
    Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6393S-6S. PubMed ID: 15448037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of non-clear cell renal cell carcinoma: Current approaches.
    Tsimafeyeu I
    Urol Oncol; 2017 Jan; 35(1):5-13. PubMed ID: 27544302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.